QRG Capital Management Inc. reduced its holdings in HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 30.1% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 48,430 shares of the company’s stock after selling 20,806 shares during the quarter. QRG Capital Management Inc.’s holdings in HCA Healthcare were worth $22,919,000 at the end of the most recent quarter.
Several other institutional investors have also added to or reduced their stakes in the stock. Palisade Asset Management LLC purchased a new stake in HCA Healthcare in the third quarter worth about $26,000. Holos Integrated Wealth LLC purchased a new position in shares of HCA Healthcare in the 4th quarter valued at approximately $29,000. Ares Financial Consulting LLC purchased a new stake in HCA Healthcare in the fourth quarter worth $31,000. JPL Wealth Management LLC bought a new stake in shares of HCA Healthcare during the 3rd quarter valued at $33,000. Finally, Aventura Private Wealth LLC bought a new position in shares of HCA Healthcare in the 4th quarter worth about $34,000. 62.73% of the stock is currently owned by institutional investors.
HCA Healthcare Price Performance
Shares of HCA opened at $409.99 on Friday. The firm has a market capitalization of $90.95 billion, a P/E ratio of 14.10, a PEG ratio of 1.30 and a beta of 1.12. The business has a fifty day moving average of $400.65 and a 200 day moving average of $462.43. HCA Healthcare, Inc. has a one year low of $330.00 and a one year high of $556.52.
HCA Healthcare Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th were issued a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend was Tuesday, June 16th. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.73%.
Analyst Ratings Changes
A number of equities analysts have weighed in on the stock. Royal Bank Of Canada decreased their target price on shares of HCA Healthcare from $593.00 to $534.00 and set an “outperform” rating for the company in a research note on Monday, April 27th. Wall Street Zen downgraded HCA Healthcare from a “buy” rating to a “hold” rating in a report on Saturday, May 2nd. Barclays dropped their price target on shares of HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating on the stock in a research note on Monday, April 27th. Sanford C. Bernstein decreased their target price on shares of HCA Healthcare from $503.00 to $413.00 and set a “market perform” rating for the company in a report on Thursday, June 4th. Finally, Deutsche Bank Aktiengesellschaft reduced their price target on shares of HCA Healthcare from $558.00 to $540.00 and set a “buy” rating for the company in a research report on Tuesday, April 28th. Fifteen equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $503.00.
Read Our Latest Analysis on HCA
HCA Healthcare Profile
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Read More
- Five stocks we like better than HCA Healthcare
- AST SpaceMobile’s Japan Catalyst Puts Its Rollout Story Back in Focus
- Gold and Silver Recovery—3 Precious Metals Stocks for H2 2026
- Klarna’s Google Court Win Could Give Its BNPL Story a Needed Cash Catalyst
- Why Kroger’s Giant Eagle Deal Could Change Everything
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
